Potential pharmacological candidates Transmembrane protease, serine 2 inhibitors 2019-ncov treatment
ABSTRACT Introduction: Coronavirus disease 2019 (COVID-19) caused by the SARS-CoV-2 virus with characteristic of infecting the respiratory tract, causing severe acute respiratory syndrome. The virus uses the ACE II receptors and the transmembrane protein TMPRSS2 initial step to enter the host cell,...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Book |
| Published: |
Facultad de Farmacia, Universidad de Granada,
2021-01-01T00:00:00Z.
|
| Subjects: | |
| Online Access: | Connect to this object online. |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|